Cytokinetics, Inc. (CYTK)
70.91
-1.18
(-1.64%)
USD |
NASDAQ |
Aug 31, 16:00
70.91
0.00 (0.00%)
After-Hours: 20:00
Cytokinetics Cash from Operations (TTM) : -555.45M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -555.45M |
| March 31, 2026 | -523.85M |
| December 31, 2025 | -510.01M |
| September 30, 2025 | -432.93M |
| June 30, 2025 | -426.92M |
| March 31, 2025 | -398.00M |
| December 31, 2024 | -395.89M |
| September 30, 2024 | -404.36M |
| June 30, 2024 | -399.06M |
| March 31, 2024 | -421.55M |
| December 31, 2023 | -414.33M |
| September 30, 2023 | -438.49M |
| June 30, 2023 | -423.91M |
| March 31, 2023 | -392.58M |
| December 31, 2022 | -299.52M |
| September 30, 2022 | -246.06M |
| June 30, 2022 | -203.20M |
| March 31, 2022 | -142.22M |
| December 31, 2021 | -142.52M |
| September 30, 2021 | -45.64M |
| June 30, 2021 | 7.502M |
| March 31, 2021 | 9.559M |
| December 31, 2020 | 8.943M |
| September 30, 2020 | -62.26M |
| June 30, 2020 | -96.90M |
| Date | Value |
|---|---|
| March 31, 2020 | -94.14M |
| December 31, 2019 | -90.91M |
| September 30, 2019 | -84.18M |
| June 30, 2019 | -96.15M |
| March 31, 2019 | -98.32M |
| December 31, 2018 | -101.22M |
| September 30, 2018 | -112.96M |
| June 30, 2018 | -106.21M |
| March 31, 2018 | -110.62M |
| December 31, 2017 | -101.76M |
| September 30, 2017 | 0.141M |
| June 30, 2017 | 13.50M |
| March 31, 2017 | 33.54M |
| December 31, 2016 | 36.98M |
| September 30, 2016 | -50.79M |
| June 30, 2016 | -49.01M |
| March 31, 2016 | -46.98M |
| December 31, 2015 | 4.883M |
| September 30, 2015 | 6.695M |
| June 30, 2015 | 7.527M |
| March 31, 2015 | 7.338M |
| December 31, 2014 | -44.84M |
| September 30, 2014 | -49.14M |
| June 30, 2014 | -29.32M |
| March 31, 2014 | -13.32M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Bristol Myers Squibb Co. | 12.78B |
| Krystal Biotech, Inc. | 272.34M |
| Ionis Pharmaceuticals, Inc. | -496.43M |
| Vertex Pharmaceuticals, Inc. | 4.293B |
| Alnylam Pharmaceuticals, Inc. | 885.89M |